Abstract
Septic arthritis of the native joint is an uncommon infection but, when present, creates a significant risk for functional impairment of the affected joint or, in severe cases, mortality. Knowledge of the most common pathogens, as well as appropriate diagnostics, can facilitate earlier diagnosis and treatment, which, ideally, leads to improved long-term outcomes. In this article, we discuss recent microbiologic trends and diagnostic tests, with an update on use of molecular testing. Empiric antibiotic regimens for native joint septic arthritis are reviewed, as well as potential new therapies on the horizon.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
